Head-to-head comparison of structurally unrelated dipeptidyl peptidase 4 inhibitors in the setting of renal ischemia reperfusion injury.

DPP4 inhibitor treatment did not affect plasma cystatin C concentrations at any point but showed a trend towards a reduction of plasma osteopontin levels.

also in 53,322 other papers

Treatment with DPP4 inhibitors resulted in numerically lower plasma osteopontin concentrations compared with the placebo group, but these differences did not reach statistical significance at any point (Figure 1 B).

also in 111,027 other papers